Hebei Senlang Biotechnology Co., Ltd.
PrivateLast Round
Early Funding
May 18, 2022
Total Funding Raised
$29.6M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Hebei Senlang Biotechnology Co., Ltd. operates in Healthcare & Life Sciences and is based in Shijiazhuang. Its latest recorded funding round was an Early Funding round in May 2022.
Hebei Senlang Biotechnology Co., Ltd. is a biotechnology company that develops tumor cell immunotherapy products, including CAR-T and other cell therapy platforms for the treatment of hematological and lymphoid malignancies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hebei Senlang Biotechnology Co., Ltd. Comparables
Compare Hebei Senlang Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Allotera Therapeutics | 77% | |
| Bioceltech Therapeutics, Ltd. | 39% | |
| Shanghai Unicar-Therapy Bio-medicine Technology | 35% |
For institutional investors. Book with your work email.
Hebei Senlang Biotechnology Co., Ltd. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 2163% MoM, from 27 to 611.
- May 18, 2022
Raised $30M in early funding.
For institutional investors. Book with your work email.
Hebei Senlang Biotechnology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Hebei Senlang Biotechnology Co., Ltd.'s valuation, stock price, and market status.
Is Hebei Senlang Biotechnology Co., Ltd. a public or private company?
Hebei Senlang Biotechnology Co., Ltd. is a private company.
What is the current stock price of Hebei Senlang Biotechnology Co., Ltd.?
Hebei Senlang Biotechnology Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Hebei Senlang Biotechnology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Hebei Senlang Biotechnology Co., Ltd. worth (valuation)?
Valuation information for Hebei Senlang Biotechnology Co., Ltd. is not publicly available.
Can I buy Hebei Senlang Biotechnology Co., Ltd. stock?
Hebei Senlang Biotechnology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Hebei Senlang Biotechnology Co., Ltd.'s last funding round?
Hebei Senlang Biotechnology Co., Ltd.'s most recent funding round was Early Funding on May 18, 2022.
Who are the main investors in Hebei Senlang Biotechnology Co., Ltd.?
Investor information for Hebei Senlang Biotechnology Co., Ltd. is not publicly disclosed.
Will Hebei Senlang Biotechnology Co., Ltd. IPO soon?
No public IPO plans have been announced for Hebei Senlang Biotechnology Co., Ltd..
How can I track Hebei Senlang Biotechnology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Hebei Senlang Biotechnology Co., Ltd.'s shares on secondary markets.